Abstract:In this work, a functionalized polycaprolactone (PCL) composite fiber combining calf-type I collagen (CO) and natural drug usnic acid (UA) was prepared, in which UA was used as an antibacterial agent. Through 3D near-field electrospinning, the mixed solution was prepared into PCL/CO/UA composite fibers (PCUCF), which has a well-defined perfect arrangement structure. The influence of electrospinning process parameters on fiber diameter was investigated, the optimal electrospinning parameters were determined, and the electric field simulation was conducted to verify the optimal parameters. The addition of 20% collagen made the composite fiber have good hydrophilicity and water absorption property. In the presence of PCUCF, 1% UA content significantly inhibited the growth rate of Gram-positive and negative bacteria in the plate culture. The AC-PCUCF (after crosslinking PCUCF) prepared by crosslinking collagen with genipin showed stronger mechanical properties, water absorption property, thermal stability, and drug release performance. Cell proliferation experiments showed that PCUCF and AC-PCUCF had no cytotoxicity and could promote cell proliferation and adhesion. The results show that PCL/CO/UA composite fiber has potential application prospects in biomedical dressing.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop a PCL/collagen/ursolic acid (UA) composite biomedical dressing with an ordered microfiber structure in order to improve the deficiencies of traditional materials in biomedical applications. Specifically: 1. **Improve antibacterial performance**: By introducing the natural drug ursolic acid (Usnic Acid, UA), significant antibacterial properties are imparted to the composite fibers, effectively inhibiting the growth of Gram - positive and - negative bacteria. 2. **Enhance water absorption and hydrophilicity**: By adding 20% collagen, the composite fibers possess good hydrophilicity and water - absorption, which are very important for wound healing. 3. **Optimize mechanical properties and thermal stability**: By using near - field electrospinning technology (Near - Field Electrospinning, NFES) to prepare a highly ordered microfiber structure and combining with gene - level cross - linking technology, the mechanical properties, thermal stability and drug - release properties of the composite fibers are enhanced. 4. **Ensure biocompatibility and cell proliferation ability**: The experimental results show that both the PCL/collagen/ursolic acid composite fibers and their cross - linked version (AC - PCUCF) are non - cytotoxic and can promote cell proliferation and adhesion, and are suitable for the treatment and repair of skin wounds. 5. **Make up for the defects of materials prepared by a single technology**: By rationally designing the NFES process, biomaterials (PCL and collagen), active drugs (UA) and other components are directly prepared into microfiber - structured biomaterials, overcoming the problems of uneven material size and distribution in traditional methods and improving the overall performance of the materials. In summary, this research aims to develop a high - performance composite biomedical dressing to meet the needs of skin wound treatment and repair and show its potential application prospects. ### Key formulas - **Tensile strength calculation formula**: \[ P=\frac{F}{a\times b} \] where \(P\) is the tensile strength, \(F\) is the maximum tensile force that the fiber web can withstand, \(a\) is the thickness of the fiber web, and \(b\) is the width of the fiber web. - **Elongation at break calculation formula**: \[ \delta=\left(\frac{L - L_0}{L_0}\right)\times100\% \] where \(\delta\) represents the elongation at break, \(L\) is the length when the fiber web breaks, and \(L_0\) is the original length. - **Water absorption rate calculation formula**: \[ \text{Water absorption rate}=\left(\frac{m - m_0}{m_0}\right)\times100\% \] where \(m\) is the weight of the sample after soaking, and \(m_0\) is the original weight. - **Cumulative drug - release percentage calculation formula**: \[ \text{Cumulative drug - release percentage}=\left(\frac{W_t}{W_0}\right)\times100\% \] where \(W_t\) is the drug - release amount at different time points, and \(W_0\) is the ursolic acid content in the composite fibers.

PCL/Collagen/UA Composite Biomedical Dressing with Ordered Microfiberous Structure Fabricated by a 3D Near-Field Electrospinning Process